Low versus high dose Botulinum Toxin A in Axillary Hyperhidrosis
ISRCTN | ISRCTN05152123 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN05152123 |
Secondary identifying numbers | N0065149382 |
- Submission date
- 30/09/2005
- Registration date
- 30/09/2005
- Last edited
- 01/05/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr J A A Langtry
Scientific
Scientific
Department of Dermatology
Sunderland Royal Hospital
Kayll Road
Sunderland
SR4 7TP
United Kingdom
Study information
Study design | Randomised controlled intra-individual single-blinded study |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | Low versus high dose Botulinum Toxin A in Axillary Hyperhidrosis |
Study objectives | To compare the efficacy of fewer injections of a higher dose (5U) to the conventional practice of numerous smaller dose (2U) injections. We aim to compare the total amount and area of sweating of these two regimes and their comfort for the patient. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Signs and Symptoms: Axillary hyperhidrosis |
Intervention | Higher dose (5U) vs conventional practice of numerous smaller dose (2U) injections |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Specified |
Drug / device / biological / vaccine name(s) | Botulinum Toxin A |
Primary outcome measure | Patient comparison of the total amount and area of sweating by gravimetric (weighing total amount of sweat) and starch-iodine (demarcating area of sweat) testing respectively between the axillae treated with 2U BTX-A per injection to that treated with 5U BTX-A |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/09/2004 |
Completion date | 01/03/2006 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | Approximately 28 patients will be recruited |
Key inclusion criteria | Not provided at time of registration |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 01/09/2004 |
Date of final enrolment | 01/03/2006 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Sunderland Royal Hospital
Sunderland
SR4 7TP
United Kingdom
SR4 7TP
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)20 7307 2622 |
---|---|
dhmail@doh.gsi.org.uk | |
Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
City Hospitals Sunderland NHS Trust (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |